A. Beech (Manchester, United Kingdom), M. Adner (Stockholm, Sweden)
IMPALA: efficacy measures in patients who required whole lung lavage
B. Chowdhury (Austin, United States), J. Bennett (Raleigh, United States), D. Desai (Austin, United States), Y. Inoue (Osaka, Japan), Y. Inoue (Osaka, Japan)
|   |
Assessing human lung pharmacokinetics using exhaled breath particles (PEx)
O. Holz (Hannover, Germany), M. Sadiq (Gothenburg, Sweden), J. Nehrig (Hannover, Germany), B. Ellinghusen (Hannover, Germany), N. Struß (Hannover, Germany), U. Eriksson (Gothenburg, Sweden), M. Fridén (Gothenburg, Sweden), S. Stomilovic (Gothenburg, Sweden), A. Lundqvist (Gothenburg, Sweden), J. Hohlfeld (Hannover, Germany)
| |
Improvements in Awake Cough Frequency in SOOTHE, A Phase 2b Trial of BLU-5937 in Refractory Chronic Cough
J. Smith (Manchester, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), A. Morice (Cottingham, United Kingdom), S. Birring (London, United Kingdom), J. Hull (London, United Kingdom), S. Lanouette (Montreal, Canada), R. Yang (Wilmington, United States), K. Bartholomew (Wilmington, United States), L. Harvey (Montreal, Canada), M. Garin (Wilmington, United States), C. Bonuccelli (Wilmington, United States)
| |
The Effect of Inhaled Salbutamol on Mannitol Evoked Cough Responses: A Double-Blind Randomized Placebo Controlled 2-way Cross-Over Study
M. Wahab (Hamilton, Canada), R. Cusack (Hamilton, Canada), C. Obminski (Hamilton, Canada), K. Howie (Hamilton, Canada), A. Schlatman (Hamilton, Canada), K. Killian (Hamilton, Canada), P. Obyrne (Hamilton, Canada), I. Satia (Hamilton, Canada), G. Gauvreau (Hamilton, Canada)
| |
Real World Effectiveness and Tolerability of low-dose opiates for Refractory/Unexplained Chronic Cough (RCC/UCC) in a tertiary clinic
J. King (Manchester (Greater Manchester), United Kingdom), J. Wingfield-Digby (Manchester (Greater Manchester), United Kingdom), S. Hennessey (Manchester (Greater Manchester), United Kingdom), A. Woodcock (Manchester (Greater Manchester), United Kingdom), J. Smith (Manchester (Greater Manchester), United Kingdom), P. Marsden (Manchester (Greater Manchester), United Kingdom), J. Wingfield Digby (Manchester (Greater Manchester), United Kingdom)
| |
Safety and tolerability of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis (aPAP)
F. Bonella (Essen, Germany), J. Bennett (Raleigh, United States), B. Chowdhury (Austin, United States), D. Desai (Austin, United States)
| |
Efficacy in SOOTHE, A Phase 2b Trial of BLU-5937 In Refractory Chronic Cough, Was Not Dependant of Taste Disturbance Adverse Events
S. Birring (London, United Kingdom), J. Smith (Manchester, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), A. Morice (Cottingham, United Kingdom), A. Goldsobel (San Jose, United States), S. Lanouette (Montreal, Canada), R. Yang (Wilmington, United States), A. Levengood (Wilmington, United States), M. Garin (Wilmington, United States), C. Bonuccelli (Wilmington, United States)
| |
Characteristics of Participants with Refractory Chronic Cough Enrolled in A Phase 2b Trial of BLU-5937
A. Morice (Cottingham, United Kingdom), J. Smith (Manchester, United Kingdom), S. Birring (London, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), P. Dicpinigaitis (New York, United States), M. Sher (Largo, United States), S. Lanouette (Montreal, Canada), R. Yang (Wilmington, United States), M. Garin (Wilmington, United States), C. Bonuccelli (Wilmington, United States)
| |
Suicidal ideation, depression and anxiety in chronic cough
B. Hirons (London, United Kingdom), K. Rhatigan (London, United Kingdom), A. Simpson (London, United Kingdom), H. Kesavan (London, United Kingdom), R. Turner (London, United Kingdom), J. Hull (London, United Kingdom), M. Docherty (London, United Kingdom), C. Jolley (London, United Kingdom), S. Birring (London, United Kingdom), P. Cho (London, United Kingdom)
| |
Health-related quality of life and its determinants in patients with chronic cough: a case-control study
N. Kang (Seoul, Republic of Korea), H. Won (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), J. Shim (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), S. Kang (Incheon, Republic of Korea), H. Park (Daegu, Republic of Korea), E. Jo (Busan, Republic of Korea), S. Lee (Yangsan, Republic of Korea), S. Kim (Seoul, Republic of Korea), S. Kim (Seongnam, Republic of Korea), Y. Chang (Seongnam, Republic of Korea), B. Lee (Seoul, Republic of Korea), . Jo (Seoul, Republic of Korea), W. Song (Seoul, Republic of Korea)
| |
IMPALA-2: choice of DLCO as a primary endpoint in aPAP
B. Trapnell (Cincinnati, United States), D. Desai (Austin, United States), B. Chowdhury (Austin, United States)
| |
Canadian health care professionals’ perceptions on the management and effectiveness of treatment of chronic cough – results from a healthcare sample survey
N. Diab (Hamilton, Canada), E. Kum (Hamilton, Canada), M. Wahab (Hamilton, Canada), T. Abraham (Montreal, Canada), S. Sahakian (Montreal, Canada), P. Hernandez (Halifax, Canada), H. Kim (London, Canada), M. Cormier (Montreal, Canada), P. Lin (Toronto, Canada), A. Ellis (Kingston, Canada), L. Boulet (Quebec City, Canada), A. Kaplan (Toronto, Canada), S. Field (Calgary, Canada), I. Satia (Hamilton, Canada)
| |
Analysis of transport mechanisms of substances applied to the airways in a transparent airway model
C. Cornelissen (Aachen, Germany), A. Thiebes (Aachen, Germany), M. Dreher (Aachen, Germany), S. Gürzing (Aachen, Germany), M. Reddemann (Aachen, Germany)
| |
The effect of the COVID-19 pandemic on severe asthma care in Europe - will care change for good?
K. Eger (Amsterdam, Netherlands), P. Dora (Szeged, Hungary), B. Alison (Plymouth, United Kingdom), S. Florence (Liege, Belgium), S. Svetlana (Tallinn, Estonia), B. Arnaud (Montpellier, France), V. Isabelle (Montpellier, France), Z. Eleftherios (Athens, Greece), K. Konstantinos (Thessaloniki, Greece), P. Dimosthenis (Athens, Greece), K. Konstantinos (Ioannina, Greece), C. Zsuzsanna (Koranyi, Hungary), H. Enrico (Milan, Italy), G. Canonica (Milan, Italy), G. Ineta (Riga, Latvia), B. Kristina (Kaunas, Lithuania), P. Jolita (Kaunas, Lithuania), T. Anneke (Leeuwarden, Netherlands), S. Hashimoto (Amsterdam, Netherlands), S. Frank Wjm (Eindhoven, Netherlands), B. Gert-Jan (Rotterdam, Netherlands), V. Simone (Breda, Netherlands), M. Florin (Bucarest, Romania), N. Natalia (Moscow, Russian Federation), P. Marina (Moscow, Russian Federation), Z. Biljana (Sremska Kamenica, Republic of Serbia), C. Ivan (Kragujevac, Republic of Serbia), H. Sanja (Sremska Kamenica, Republic of Serbia), C. Vojislav (Kragujevac, Republic of Serbia), L. Zorica (Kragujevac, Republic of Serbia), M. Branislava (Belgrade, Republic of Serbia), D. Sanja (Belgrade, Republic of Serbia), Y. Valentyna (Stockholm, Sweden), D. Barbro (Stockholm, Sweden), B. Apostolos (Stockholm, Sweden), L. Nikolaos (Stockholm, Sweden), A. David (Lund, Sweden), E. Arne (Lund, Sweden), M. Abdul Kashem Mohammad (Lund, Sweden), A. Lars (Linköping, Sweden), J. Christer (Uppsala, Sweden), Š. Sabina ( Ljubljana, Slovenia), E. Natalija (Maribor, Slovenia), L. Joerg (Basel, Switzerland), J. Fabienne (Basel, Switzerland), R. Jochen (Bern, Switzerland), P. Nikolay (Bern, Switzerland), G. Pietro (Lugano, Switzerland), F. Reta (Bern, Switzerland), C. Florian (Geneva, Switzerland), C. Rekha (Newcastle, United Kingdom), S. Steven James (Newcastle, United Kingdom), D. Simon (Newcastle, United Kingdom), F. Michelle (Newcastle, United Kingdom), M. Matthew (Exeter, United Kingdom), H. Liam (Belfast, United Kingdom), H. Hans Michael (Southampton, United Kingdom), K. Ramesh (Southampton, United Kingdom), F. Olivia (Sheffield, United Kingdom), F. Betty (Sheffield, United Kingdom), G. Toni (Sheffield, United Kingdom), N. Karen (Sheffield, United Kingdom), H. Peter (Brentford, United Kingdom), D. Ratko (Southampton, United Kingdom), B. Elisabeth (Amsterdam, Netherlands), H. Michael (Plymouth, United Kingdom), D. Paróczai (Deszk, Hungary)
| |
EVALUATION OF INCIDENCE AND COMPLICATIONS DURING COVID-19 DESEASE IN PATIENTS WITH ASTHMA
J. Pavon Guede (Madrid, Spain), P. Freund (Madrid, Spain), R. Camperos Moreno (Madrid, Spain), I. De Agrela Mendes (Madrid, Spain), K. Pose (Madrid, Spain), I. Fernández Concha Llona (Madrid, Spain), D. Laorden Escudero (Madrid, Spain), C. Carpio Segura (Madrid, Spain), J. Domínguez Ortega (Madrid, Spain), D. Romero Ribate (Madrid, Spain), I. Losantos García (Madrid, Spain), S. Quirce (Madrid, Spain), R. Álvarez-Sala Walther (Madrid, Spain)
| |
The perspective of clinical pharmacologist: what is the safety of complex polypharmacy in hospitalized COVID-19 patients?
O. Kovalenko (Dnipro, Ukraine), V. Rudakova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), N. But (Dnipro, Ukraine)
| |
Validity of a pathological score in the assessment of severe uncontrolled asthma
C. Gomez (Palma De Mallorca, Spain), H. Shafiek (Alexandria, Egypt), A. Iglesias (Palma De Mallorca, Spain), M. Mosteiro (Palma De Mallorca, Spain), A. Gonzalez-Piñeiro (Vigo, Spain), M. Rodríguez (Salamanca, Spain), M. García-Cosío (Madrid, Spain), E. Busto (Lugo, Spain), J. Martin (Madrid, Spain), M. Saiz (Madrid, Spain), B. Paz (Madrid, Spain), A. Benito (Madrid, Spain), L. Mejías (Madrid, Spain), L. Lopez Vilaro (Barcelona, Spain), B. G. Cosio (Palma De Mallorca, Spain)
| |
A case of excavated pneumopathy after bronchial thermoplasty
M. Steger (Strasbourg, France), N. Khayath (Strasbourg, France), M. Ohana (Strasbourg, France), N. Migueres (Strasbourg, France), C. Marcot (Strasbourg, France), F. De Blay (Strasbourg, France), N. Migueres (Strasbourg, France)
| |
Formoterol exerts anti-cancer effects modulating oxidative stress and EMT processes in CSE exposed lung adenocarcinoma cells
M. Ferraro (Palermo (PA), Italy), S. Di Vincenzo (Palermo (PA), Italy), S. Taverna (Palermo (PA), Italy), E. Pace (Palermo (PA), Italy)
| |